Our Expertise > Corporate > Capital Markets & IPOs
Capital Markets & IPOs
Related expertise
Campbells’ Capital Markets team provides comprehensive legal advice across the full spectrum of equity and debt capital markets transactions, combining deep expertise in Cayman Islands and British Virgin Islands law with practical experience in cross-border capital raising. With a specific focus on assisting clients and corporations in Mainland China, Hong Kong, Taiwan and other Asian countries, our team has a vast amount of experience in both equity and debt capital markets. Our Hong Kong office prides itself on being a pivotal player and one of the top five offshore law firms in the initial public offering arena.
Equity Capital Markets
Our team has extensive experience advising clients on listings and floats on major international stock exchanges, including the New York Stock Exchange (NYSE), NASDAQ, the Hong Kong Stock Exchange (HKEX), the Shanghai Stock Exchange (SSE), the Shenzhen Stock Exchange (SZSE) and the Taiwan Stock Exchange (TWSE). We handle every stage of the process, from the formation of offshore structures to advising on pre-IPO restructuring and financing, to preparing listing documents, coordinating with regulators, sponsors, and other professional parties, and managing post-listing compliance, guiding clients through the regulatory and legal requirements of their listing projects.
Debt Capital Markets
Complementing our equity practice, we provide specialist advice on all forms of debt capital markets activity, including high-yield and investment-grade bond issuances, digital bonds, panda bonds, and other debt instruments. Our team has extensive experience advising on the listing of bonds on international stock exchanges, including the Stock Exchange of Hong Kong Limited (HKEX) and the Chongwa (Macao) Financial Asset Exchange Co., Ltd. (MOX).
Clients value our ability to combine technical rigour with a pragmatic, solutions-oriented approach. Whether advising a blue-chip multinational on a landmark listing or a first-time issuer navigating the public markets, we are committed to providing responsive, partner-led service at every stage of the transaction.
-
Work Highlights
- Chuangxin Industries Holdings Limited, on its listing on the HKEX, the Hong Kong Public Offering of which was oversubscribed by around 450 times
- Bloks Group Limited, on its listing on the HKEX, the Hong Kong Public Offering of which was oversubscribed by around 6,000 times, the second highest on record for companies successfully listed in Hong Kong, attracted a total sum of HK$873.3 billion of subscription funds, which was the highest in the history of the HKIPO market at the time of its listing.
- Beauty Farm Medical and Health Industry Inc., the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China, on its listing on the HKEX
- Peijia Medical Limited, on its listing on the HKEX, which was the second largest Hong Kong IPO in 2020, with its Hong Kong Public Offering oversubscribed by 1200 times.
- Akeso, Inc., on its listing on the HKEX, which was the biggest Hong Kong IPO in 2020. Its Hong Kong Public Offering was over-subscribed by 639 times, setting the highest record amount under Hong Kong’s listing regime for biotechnology firms under Chapter 18A of the Listing Rules at the time of its listing.
- Huafa 2024 I Company Limited (subsidiary of Zhuhai Huafa Group Co., Ltd.), on its groundbreaking issuance and listing of its Guaranteed Digitally Native Bonds, the first-ever digital bonds issued by a BVI issuer and dual-listed on HKEX and the MOX
Our key contacts
